Jeff Healey - Articles and news items

Boehringer Ingelheim logo

Large scale registry shows atrial fibrillation management is suboptimal and unequal around the world

Industry news, News / 29 August 2012 / Boehringer Ingelheim

New one-year follow-up results from the global RE-LY AF registry…

Boehringer Ingelheim logo

AF patients who require surgery benefit from a shorter treatment interruption on dabigatran etexilate (Pradaxa®) compared to warfarin

Industry news, News / 18 June 2012 / Boehringer Ingelheim

Pradaxa® is associated with a substantially shorter interruption of oral anticoagulation therapy…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+